CAR-T Cell Therapy and Cell-Based Treatments

CAR-T Cell Therapy and Cell-Based Treatments are innovative cancer treatments that involve modifying a patient’s own immune cells to recognize and attack cancer cells. CAR-T (Chimeric Antigen Receptor T-cell) therapy involves collecting T-cells from the patient’s blood, genetically altering them to express a receptor that targets cancer cells, and then re-infusing them into the patient. This enables the T-cells to specifically seek out and destroy cancer cells. Cell-based treatments may also include other immune cells, like natural killer (NK) cells or dendritic cells, which are enhanced or engineered to target and kill cancer cells more effectively. These therapies have shown significant success, particularly in treating certain blood cancers like leukemia and lymphoma, and are being expanded for use in solid tumors.

    Related Conference of CAR-T Cell Therapy and Cell-Based Treatments

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CAR-T Cell Therapy and Cell-Based Treatments Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in